Navigation Links
Autism discovery paves way for early blood test and therapeutic options
Date:6/6/2013

Greenwood, SC (June 5, 2013) - Researchers at the JC Self Research Institute of the Greenwood Genetic Center (GGC), along with collaborators from Biolog, Inc. in California, have reported an important discovery in the understanding of autism which was published this week in Molecular Autism.

The study, led by GGC's Director of Research, Charles Schwartz, PhD and Staff Scientist, Luigi Boccuto, MD, found that individuals with autism spectrum disorders (ASDs) showed significantly decreased metabolism of the amino acid L-tryptophan when compared to both typical controls and individuals with other neurodevelopmental disorders. Cells from individuals with autism metabolized L-tryptophan at a decreased rate whereas cells from individuals without autism did not show this change.

Researchers also measured the expression of genes that are known to be involved in L-tryptophan metabolism in a small subset of patients with autism and found they also expressed some of the genes at lower levels than those without autism.

"The important and immediate implication of this work is the development of a simple, early blood screening test for autism by measuring the metabolism of L-tryptophan using Biolog's technology," shared Dr. Boccuto. Biolog's assay method, called Phenotype MicroArray technology, allows researchers to measure the ability of cells to generate energy from various biochemical nutrients, including L-tryptophan.

Currently there are no laboratory tests that can accurately diagnose ASDs, which are estimated to affect 1 in 50 school-aged children in the US. Current diagnosis depends upon a developmental evaluation and parent interviews and can often not be made prior to 2-3 years of age. "A screening, and eventually, a diagnostic blood test for autism would be of immense value to families," explained Dr. Schwartz. "An early, accurate diagnosis is key to providing effective and timely therapies for these patients and thei
'/>"/>

Contact: Lori Bassett
lbassett@ggc.org
864-388-1061
Greenwood Genetic Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Over-produced autism gene alters synapses, affects learning and behavior in mice
2. Bigger birth weight babies at greater risk of autism
3. Epigenetic changes shed light on biological mechanism of autism
4. In autism, age at diagnosis depends on specific symptoms
5. Autism in black and white: NIH grant helps scientist study disorder in African Americans
6. Atypical brain circuits may cause slower gaze shifting in infants who later develop autism
7. Folic acid lowers risk of autism
8. Speech emerges in children with autism and severe language delay at greater rate than thought
9. Ultrasound reveals autism risk at birth
10. Researcher uncovers potential cause, biomarker for autism and proposes study to investigate theory
11. UCI research turns the corner on autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2015)... Conn. , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, announces ... in a news clip that aired this week on ... ) . In a segment "The Next Great ... wallet ,a new way to pay, and ,a really big ...
(Date:3/17/2015)... MedNet Solutions , a global ... management systems, is pleased to announce that company ... in Clinical Trials Southeast conference – March 24-25 ... forum for MedNet to showcase iMedNet , ... eClinical technology platform. We strongly encourage ...
(Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... Purdue University researchers are collaborating with Chrysler LLC in ... from a contaminated site in north-central Indiana. The ... a former oil storage facility near Kokomo, Ind., this ... been shown to be capable of absorbing trichloroethylene, or ...
... -- Rice University bioengineer Jennifer West is being recognized ... scientific honors, the O,Donnell Award from The Academy of ... O,Donnell Awards, given for excellence in medical, scientific and ... an inscribed statue. West, a pioneer in the field ...
... Ala. A drug originally used to treat iron ... heal and re-grow injured bones, according to researchers at ... researchers injected the drug deferoxamine (DF), which is designed ... found DF triggered the growth of new blood vessels, ...
Cached Biology News:Fighting pollution the poplar way: Trees to clean up Indiana site 2Fighting pollution the poplar way: Trees to clean up Indiana site 3Rice's West honored as one of Texas' best researchers 2Rice's West honored as one of Texas' best researchers 3New treatment boosts bone healing and regrowth 2
(Date:4/24/2015)... 2015 PAREXEL International Corporation (NASDAQ: ... announced that Partnerships in Clinical Trials named PAREXEL,s ... Clinical Innovator of the Year.  The honor recognizes Mr. ... Company,s Perceptive MyTrials ® Data-Driven Monitoring solution. ... the 2015 Partnership Awards in Boston ...
(Date:4/23/2015)... 2015 The Thomas Brain Health ... a groundbreaking pilot study to see if early ... as little as three to six months. , ... nutritional medicine—will aggressively target and simultaneously treat the ... aging brain. These include oxidative stress, neuroinflammation, mitochondrial ...
(Date:4/23/2015)...  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... 2015 results before the Nasdaq market opens on Thursday, ... call and webcast to discuss its financial results and ... at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time). ... by dialing 866-952-1906 (US) or 785-424-1825 (International) using the ...
(Date:4/23/2015)... 2015  Veracyte, Inc. (NASDAQ: VCYT ) today ... to sell approximately $40 million of its common stock ... will purchase an aggregate of 4,907,975 shares of common ... the closing stock price on April 22, 2015. The ... including Broadfin Capital, Camber Capital, Deerfield, Longwood Capital Partners ...
Breaking Biology Technology:PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials 2PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials 3PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials 4PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials 5New Study Looks to Reverse Alzheimer’s Disease 2New Study Looks to Reverse Alzheimer’s Disease 3Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2Veracyte, Inc. Announces $40 Million Private Placement 2Veracyte, Inc. Announces $40 Million Private Placement 3Veracyte, Inc. Announces $40 Million Private Placement 4
... Complete Genomics Inc.,a newly launched, third-generation human genome ... Annual BIO Investor Forum,which will be held in San ... president and chief executive officer of,Complete Genomics, will present ... Room of the Palace Hotel, located at 2 New ...
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today that ... Conference on October 28, 2008 at 2:00 p.m.,Pacific Time ... in La,Jolla, California. Jack Lief, Arena,s President and Chief ... company, including its,clinical development and discovery programs., A ...
... demonstrated that low dose sublingual Intermezzo(R), used at ... significantly shortened time to ... Oct. 22 Transcept,Pharmaceuticals, Inc., a privately-held specialty pharmaceutical ... safety and efficacy of,its lead product candidate, Intermezzo(R) (zolpidem ...
Cached Biology Technology:Arena Pharmaceuticals to Present at the BIOCOM Investor Conference 2Arena Pharmaceuticals to Present at the BIOCOM Investor Conference 3Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP 2Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP 3Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP 4Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP 5Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP 6
... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
... cDNA Library Panels were designed for full-length ... of PCRs to identify the desired cDNA ... in a 96-well "Master Plate," where each ... Having identified the positive well(s) by gel ...
... a modification of the procedure of ... 11 , 1055 (1969). ... an A 260 of 1.0 ... cm light path). Physical Form: lyophilized ...
Biology Products: